已收录 268921 条政策
 政策提纲
  • 暂无提纲
Major Impact of Sampling Methodology on Gene Expression in Estrogen Receptor–Positive Breast Cancer
[摘要] To investigate the impact of sampling methodology on gene expression data from primary estrogen receptor–positive (ER+) breast cancer biopsies, global gene expression was measured in core-cut biopsies at baseline and surgery from patients randomly assigned to receive either two weeks of presurgical aromatase inhibitor (AI; n = 157) or no presurgical treatment (n = 56). Those genes most markedly altered in the AI group (eg, FOS, DUSP1, RGS1, FOSB) were similarly altered in the no treatment group; some widely investigated genes that were apparently unaffected in the AI group (eg, MYC) were counter-altered in the control group, masking actual AI-dependent changes. In the absence of a control group, these artefactual changes would likely lead to the most affected genes being the erroneous focus of research. The findings are likely relevant to all archival collections of ER+ breast cancer.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 肿瘤学
[关键词] gene expression;surgical procedures, operative;breast cancer;biopsy;aromatase inhibitors;perceptual masking [时效性] 
   浏览次数:14      统一登录查看全文      激活码登录查看全文